Literature DB >> 9395122

Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study.

R Schmidt1, F Fazekas, M Hayn, H Schmidt, P Kapeller, G Roob, H Offenbacher, M Schumacher, B Eber, V Weinrauch, G M Kostner, H Esterbauer.   

Abstract

Microangiopathy-related cerebral damage (MARCD) represents a common incidental MRI observation in the elderly. The risk factors of such findings are widely unknown. We therefore performed MRI in 349 randomly selected volunteers (ages 50 to 70 years) without neuropsychiatric disease, and evaluated the association of MARCD with conventional and recently suggested cerebrovascular risk factors such as apolipoprotein E genotypes, plasma concentrations of essential antioxidants and anticardiolipin antibody titres. MARCD was defined as evidence of early confluent and confluent deep white matter hyperintensities and lacunes. It was present in 71 (20.3%) subjects. Individuals with MARCD were older than those without such findings (62.7 years vs 59.6 years; P=0.0001). They had a higher rate of arterial hypertension (45.1% vs 28.1%; P=0.006) and cardiac disease (50.7% vs 37.1%; P=0.04), higher systolic blood pressure readings at exam (144.4 mmHg vs 136.7 mmHg; P=0.004), and higher serum fibrinogen concentrations (327.1 mg/dl vs 292.5 mg/dl; P=0.001). Their levels of total cholesterol (217.6 mg/dl vs 231.2; P=0.009), apolipoprotein A-I (167.3 mg/dl vs 177.4 mg/dl, P=0.02), lycopene (0.17 micromol/l vs 0.24 micromol/l; P=0.003), retinol (1.91 micromol/l vs 2.10 micromol/l; P=0.02) and alpha-tocopherol (27.55 micromol/l vs 31.14 micromol/l; P=0.001) were significantly lower. Forward stepwise regression analysis created a model of independent predictors of MARCD with age entering first (odds ratio 2.01/10 years), fibrinogen second (odds ratio 2.45/100 mg/dl), alpha-tocopherol third (odds ratio 0.55/10 micromol/l), and arterial hypertension fourth (odds ratio 1.96). The association of MARCD with various treatable clinical conditions may have preventive implications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395122     DOI: 10.1016/s0022-510x(97)00137-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

2.  Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury.

Authors:  Myriam Fornage; Thomas H Mosley; Clifford R Jack; Mariza de Andrade; Sharon L R Kardia; Eric Boerwinkle; Stephen T Turner
Journal:  Hum Genet       Date:  2006-09-22       Impact factor: 4.132

3.  Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy.

Authors:  P Kapeller; S Ropele; C Enzinger; T Lahousen; S Strasser-Fuchs; R Schmidt; F Fazekas
Journal:  J Neurol       Date:  2005-05-20       Impact factor: 4.849

4.  Prospective study of major depressive disorder with white matter hyperintensity: comparison of patients with and without lacunar infarction.

Authors:  Shogo Komaki; Haruo Nagayama; Hirochika Ohgami; Hajime Takaki; Hiromu Mori; Jotaro Akiyoshi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

5.  Plasma homocysteine and severe white matter disease.

Authors:  B Censori; T Partziguian; O Manara; M Poloni
Journal:  Neurol Sci       Date:  2007-10-31       Impact factor: 3.307

6.  Microstructural tissue damage in normal appearing brain tissue accumulates with Framingham Stroke Risk Profile Score: magnetization transfer imaging results of the Austrian Stroke Prevention Study.

Authors:  Nina Homayoon; Stefan Ropele; Edith Hofer; Petra Schwingenschuh; Stephan Seiler; Reinhold Schmidt
Journal:  Clin Neurol Neurosurg       Date:  2013-01-06       Impact factor: 1.876

Review 7.  Hypertension, cognitive decline, and dementia: an epidemiological perspective.

Authors:  Christophe Tzourio
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

8.  Inverse relationship between apolipoprotein A-I and cerebral white matter lesions: a cross-sectional study in middle-aged and elderly subjects.

Authors:  Ze-Gang Yin; Ling Li; Min Cui; Shi-Ming Zhou; Ming-Ming Yu; Hua-Dong Zhou
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

9.  Relationship between fibrinogen level and its regulatory gene with Alzheimer's disease and vascular dementia.

Authors:  Yanan Sun; Qi Li; Wei Liu; Benshu Zhang
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.